Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach
Πέτρος Αρσένος, Konstantinos Gatzoulis, Dimitris Tsiachris, Polychronis Dilaveris, Skevos Sideris, Ilias Sotiropoulos, Stefanos Archontakis, C. Antoniou, Athanasios Kordalis, Ioannis Skiadas, Konstantinos Toutouzas, Charalambos Vlachopoulos, Dimitrios Tousoulis, Konstantinos Tsioufis
Abstract
interval (> 440 ms in males and > 450 ms in females) which reflect the arrhythmogenic mechanisms for the selection of the intermediate arrhythmic risk patients in the first step. In the second step, these intermediate-risk patients undergo a programmed ventricular stimulation (PVS) for the detection of inducible, truly high-risk ICM and NICM patients, who will benefit from an implantable cardioverter defibrillator. For HCM patients, we also suggest the incorporation of the PVS either for the low HCM Risk-score patients or for the patients with one traditional risk factor in order to improve the inadequate sensitivity of the former and the low specificity of the latter.